These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10869871)

  • 21. Treatment of alcohol dependence with gamma hydroxybutyric acid.
    Caputo F; Bernardi M
    Acta Neurol Scand; 2007 May; 115(5):368; author reply 369-70. PubMed ID: 17489951
    [No Abstract]   [Full Text] [Related]  

  • 22. Gamma-hydroxybutyric acid: an evaluation of its rewarding properties in rats and mice.
    Fattore L; Martellotta MC; Cossu G; Fratta W
    Alcohol; 2000 Apr; 20(3):247-56. PubMed ID: 10869866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-hydroxybutyric acid-induced organic delirium complicated by polydrug use successfully treated with electroconvulsive therapy: a case report.
    Kjærgaard MF; Videbech P; Nørbæk JJ; Ebdrup BH
    J Med Case Rep; 2021 Dec; 15(1):596. PubMed ID: 34911580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients.
    Addolorato G; Cibin M; Caputo F; Capristo E; Gessa GL; Stefanini GF; Gasbarrini G
    Drug Alcohol Depend; 1998 Dec; 53(1):7-10. PubMed ID: 10933335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma-hydroxybutyric acid.
    Addolorato G; Gasbarrini G
    N Engl J Med; 2005 Oct; 353(15):1632-3. PubMed ID: 16224828
    [No Abstract]   [Full Text] [Related]  

  • 27. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial.
    Saitz R; Mayo-Smith MF; Roberts MS; Redmond HA; Bernard DR; Calkins DR
    JAMA; 1994 Aug; 272(7):519-23. PubMed ID: 8046805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
    Furieri FA; Nakamura-Palacios EM
    J Clin Psychiatry; 2007 Nov; 68(11):1691-700. PubMed ID: 18052562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of an ethanol withdrawal syndrome in rats by 3-hydroxybutyrate.
    Derr RF; Derr M
    Life Sci; 1985 Feb; 36(8):763-7. PubMed ID: 4038774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures.
    Alldredge BK; Lowenstein DH; Simon RP
    Am J Med; 1989 Dec; 87(6):645-8. PubMed ID: 2686433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double-blind study of Aprotininum (Trasylol) in the management of alcoholic delirium].
    Tacke B; Kempf H
    Int Pharmacopsychiatry; 1975; 10(1):37-41. PubMed ID: 1095511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
    Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
    J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of pregabalin in alcohol dependence.
    Martinotti G; Di Nicola M; Tedeschi D; Mazza M; Janiri L; Bria P
    Adv Ther; 2008 Jun; 25(6):608-18. PubMed ID: 18553183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of naltrexone on alcohol "high" in alcoholics.
    Volpicelli JR; Watson NT; King AC; Sherman CE; O'Brien CP
    Am J Psychiatry; 1995 Apr; 152(4):613-5. PubMed ID: 7694913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapies for alcohol abuse. Withdrawal and treatment.
    Saitz R; O'Malley SS
    Med Clin North Am; 1997 Jul; 81(4):881-907. PubMed ID: 9222259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.
    Addolorato G; Castelli E; Stefanini GF; Casella G; Caputo F; Marsigli L; Bernardi M; Gasbarrini G
    Alcohol Alcohol; 1996 Jul; 31(4):341-5. PubMed ID: 8879280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
    Kiefer F; Jahn H; Otte C; Demiralay C; Wolf K; Wiedemann K
    J Psychiatr Res; 2005 Sep; 39(5):545-51. PubMed ID: 15992564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.